Cargando…

Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a serious public health threat and significantly challenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant...

Descripción completa

Detalles Bibliográficos
Autores principales: Seid, Aynias, Girma, Yilak, Abebe, Ayenesh, Dereb, Eseye, Kassa, Meseret, Berhane, Nega
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281285/
https://www.ncbi.nlm.nih.gov/pubmed/37346368
http://dx.doi.org/10.2147/IDR.S412951
_version_ 1785060976543924224
author Seid, Aynias
Girma, Yilak
Abebe, Ayenesh
Dereb, Eseye
Kassa, Meseret
Berhane, Nega
author_facet Seid, Aynias
Girma, Yilak
Abebe, Ayenesh
Dereb, Eseye
Kassa, Meseret
Berhane, Nega
author_sort Seid, Aynias
collection PubMed
description BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a serious public health threat and significantly challenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant factors associated with patterns of MDR-TB among pulmonary TB patients in the Northwest Amhara, Ethiopia. METHODS: A hospital-based cross-sectional study was conducted from May 2022 to February 2023 in the Northwest Amhara, Ethiopia. Data on the participants’ socio-demographics and clinical characteristics were obtained using a pre-tested checklist. Phenotypic susceptibility testing to first-line anti-TB drugs was performed on 180 isolates by automated BD BACTEC MGIT 960 system. Logistic regression analysis was performed to determine the association of risk factors with patterns of MDR-TB. A p-value ≤0.05 was considered statistically significant. RESULTS: The overall proportion of TB with HIV co-infected cases was 19.8% (50/252). Culture positivity was confirmed in 203/252 (80.6%) of sputum samples. Among 168 isolates, the DST showed that 119 (70.8%) isolates were pan-susceptible to all first-line drugs and prevalence of any resistance to first-line drugs was 49,168 (29.2%). Among the resistant isolates, 28 (16.7%) were any mono-resistance and 12 (7.1%) were determined to be resistant to MDR-TB. TB with a previous TB treatment (aOR = 6.73, 95% CI: 1.78–25.47, p = 0.005) and HIV co-infected (aOR = 0.252, 95% CI: 0.73–0.875, p = 0.03) were significantly associated with MDR-TB. CONCLUSION: Higher prevalence of TB and MDR-TB was examined among TB patients in the study area. In the study, history of previous TB treatment was the strongest risk factor MDR-TB infection followed by TB with HIV co-infected cases. Therefore, there is a need of strengthening TB control and prevention programs to reduce the increase of TB incidence, further emergence and transmission of a public health threat of MDR-TB cases.
format Online
Article
Text
id pubmed-10281285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102812852023-06-21 Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia Seid, Aynias Girma, Yilak Abebe, Ayenesh Dereb, Eseye Kassa, Meseret Berhane, Nega Infect Drug Resist Original Research BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) has continued to be a serious public health threat and significantly challenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant factors associated with patterns of MDR-TB among pulmonary TB patients in the Northwest Amhara, Ethiopia. METHODS: A hospital-based cross-sectional study was conducted from May 2022 to February 2023 in the Northwest Amhara, Ethiopia. Data on the participants’ socio-demographics and clinical characteristics were obtained using a pre-tested checklist. Phenotypic susceptibility testing to first-line anti-TB drugs was performed on 180 isolates by automated BD BACTEC MGIT 960 system. Logistic regression analysis was performed to determine the association of risk factors with patterns of MDR-TB. A p-value ≤0.05 was considered statistically significant. RESULTS: The overall proportion of TB with HIV co-infected cases was 19.8% (50/252). Culture positivity was confirmed in 203/252 (80.6%) of sputum samples. Among 168 isolates, the DST showed that 119 (70.8%) isolates were pan-susceptible to all first-line drugs and prevalence of any resistance to first-line drugs was 49,168 (29.2%). Among the resistant isolates, 28 (16.7%) were any mono-resistance and 12 (7.1%) were determined to be resistant to MDR-TB. TB with a previous TB treatment (aOR = 6.73, 95% CI: 1.78–25.47, p = 0.005) and HIV co-infected (aOR = 0.252, 95% CI: 0.73–0.875, p = 0.03) were significantly associated with MDR-TB. CONCLUSION: Higher prevalence of TB and MDR-TB was examined among TB patients in the study area. In the study, history of previous TB treatment was the strongest risk factor MDR-TB infection followed by TB with HIV co-infected cases. Therefore, there is a need of strengthening TB control and prevention programs to reduce the increase of TB incidence, further emergence and transmission of a public health threat of MDR-TB cases. Dove 2023-06-16 /pmc/articles/PMC10281285/ /pubmed/37346368 http://dx.doi.org/10.2147/IDR.S412951 Text en © 2023 Seid et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Seid, Aynias
Girma, Yilak
Abebe, Ayenesh
Dereb, Eseye
Kassa, Meseret
Berhane, Nega
Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title_full Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title_fullStr Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title_full_unstemmed Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title_short Characteristics of TB/HIV Co-Infection and Patterns of Multidrug-Resistance Tuberculosis in the Northwest Amhara, Ethiopia
title_sort characteristics of tb/hiv co-infection and patterns of multidrug-resistance tuberculosis in the northwest amhara, ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281285/
https://www.ncbi.nlm.nih.gov/pubmed/37346368
http://dx.doi.org/10.2147/IDR.S412951
work_keys_str_mv AT seidaynias characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia
AT girmayilak characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia
AT abebeayenesh characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia
AT derebeseye characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia
AT kassameseret characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia
AT berhanenega characteristicsoftbhivcoinfectionandpatternsofmultidrugresistancetuberculosisinthenorthwestamharaethiopia